abemaciclib
eli lilly
['abema', 'breast', 'monarche,(-monarcher)', 'monarche']
 delivering fantastic talk on efficacy/safety from monarche-adjuvant abemacilib in er+/her2 high risk early bc - in local/reg/adj breast session. benefit and safety data across age groups - great to see data on older patients! #asco23 
Chief Scientific Officer, Sarah Cannon Research Institute; Thoracic Medical Oncology, Tennessee Oncology